MARIA SCHMIDT: Open Payments
NPI 1518628882 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 16 payments from 2 companies in 2025. Trend: 2023 $681 · 2024 $495 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $418 |
| Eisai Inc. | 4 | $174 |
Products named: INGREZZA, Leqembi.
Industry payments across MD — which companies pay providers there.
